ENTITY
Giant Biogene Holding

Giant Biogene Holding (2367 HK)

69
Analysis
Consumer StaplesChina
Giant Biogene Holding Co., Ltd researches, develops, manufactures, and distributes, and markets skin treatment products. The Company produces recombinant collagen and rare ginsenosides skin treatment products, functional foods, and other products. Giant Biogene Holding conducts businesses in China.
more
Refresh
23 Nov 2023 16:22

2024 High Conviction - Giant Biogene - Growth Rate Keeps Moving Higher

Giant Biogene was listed in Hong Kong IPO in 2022. It has done well since and is now trading 45% above its IPO price, but its still cheap.

Logo
391 Views
Share
27 Nov 2023 19:39Broker

Giant Biogene (2367 HK) – Pioneer in Recombinant Collagen Market

Giant Biogene is a leader in the professional skin treatment industry in China, promoting products based on bioactive ingredients, especially...

Logo
257 Views
Share
02 May 2023 09:57

Giant Biogene IPO Lock-Up - US$1.7bn Lockup Release Will Increase Free Float by 14x

Giant Biogene raised around US$70m in its Hong Kong IPO, after having downsized the deal and priced it at the low-end. Its six-month lockup will...

Logo
327 Views
Share
bullishL'Occitane
09 Aug 2023 14:05

L’Occitane (973 HK): HK$35 Offer from the Controlling Shareholder?

Shares are currently in a trading halt. The rumoured offer price of HK$35 per share is attractive and represents an all-time high price. Therefore,...

Logo
394 Views
Share
bullishL'Occitane
26 Jul 2023 02:10

L’Occitane (973 HK): Controlling Shareholder Mulling a Bid?

The presence of a significant disinterested shareholder necessitates an attractive takeover premium. Irrespective of a bid materialising, the...

Logo
477 Views
Share
x